共 50 条
- [31] Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (Pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial.JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 649S - 649SWest, HBelt, RJWakelee, HABloss, LPTaylor, LMonberg, MJYe, ZObasaju, CK
- [32] A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural MesotheliomaLUNG CANCER, 2013, 81 (03) : 422 - 427Nowak, Anna K.Brown, ChrisMillward, Michael J.Creaney, JenetteByrne, Michael J.Hughes, BrettKremmidiotis, GabrielBibby, David C.Leske, Annabell F.Mitchell, Paul L. R.Pavlakis, NickBoyer, MichaelStockler, Martin R.
- [33] Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trialLANCET RESPIRATORY MEDICINE, 2019, 7 (07): : 569 - 580Scagliotti, Giorgio V.Gaafar, RababNowak, Anna K.Nakano, Takashivan Meerbeeck, JanPopat, SanjayVogelzang, Nicholas J.Grosso, FedericaAboelhassan, RashaJakopovic, MarkoCeresoli, Giovanni L.Taylor, PaulOrlandi, FranciscoFennell, Dean A.Novello, SilviaScherpereel, ArnaudKuribayashi, KozoCedres, SusanaSorensen, Jens BennPavlakis, NickReck, MartinVelema, Derekvon Wangenheim, UteKim, MiyoungBarrueco, JoseTsao, Anne S.
- [34] A PHASE II CLINICAL TRIAL OF PACLITAXEL/CISPLATIN/S-1 TRIPLET COMBINATION CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER AS FIRST-LINE THERAPYANNALS OF ONCOLOGY, 2008, 19 : 173 - 173Song, H. S.Do, Y. R.Lee, W. S.Kim, J. G.Chae, Y. S.Lee, K. H.Kim, M. K.Rhoo, H.Park, K.Baek, J. H.
- [35] Checkmate 743: A phase 3 randomized, open-label trial of nivolumab (nivo) plus ipilimumab (ipi) vs pemetrexed plus cisplatin or carboplatin as first-line therapy in unresectable pleural mesothelioma.JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Zalcman, GerardPeters, SolangeMansfield, Aaron ScottJahan, Thierry MariePopat, SanjayScherpereel, ArnaudHu, WenhuaSelvaggi, GiovanniBaas, Paul
- [36] Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancerJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (02) : 132 - 137Shoji, HirokazuMorizane, ChigusaSakamoto, YasunariKondo, ShunsukeUeno, HidekiTakahashi, HidekiOhno, IzumiShimizu, SatoshiMitsunaga, ShuichiIkeda, MasafumiOkusaka, Takuji
- [37] Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multi-centre, single-arm phase 2 trial (vol 20, pg 1702, 2019)LANCET ONCOLOGY, 2020, 21 (02): : E70 - E70Ceresoli, G. L.Aerts, J. G.Dziadziuszko, R.
- [38] VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase iii, Randomized, Double-Blind, Placebo-Controlled TrialEUROPEAN JOURNAL OF CANCER, 2011, 47 : 2 - 3Krug, L. M.Kindler, H.Calvert, H.Manegold, C.Tsao, A. S.Fennell, D.Lubiniecki, G. M.Sun, X.Smith, M.Baas, P.
- [39] PrE0505: Phase II multicenter study of anti-PD-L1, durvalumab, in combination with cisplatin and pemetrexed for the first-line treatment of unresectable malignant pleural mesothelioma (MPM)-A PrECOG LLC study.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Forde, Patrick M.Sun, ZhuoxinAnagnostou, ValsamoKindler, Hedy L.Purcell, William T.Goulart, Bernardo H. L.Dudek, Arkadiusz Z.Borghaei, HosseinBrahmer, Julie R.Ramalingam, Suresh S.
- [40] Granular analysis of individual immune-related gene expression in a randomized phase I/II study of the oncolytic adenovirus, ONCOS-102, in combination with pemetrexed/cisplatin (P/C) in patients (pts) with unresectable malignant pleural mesothelioma (MPM)JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Birkballe Hansen, ThomasCedres Perez, SusanaRicordel, CharlesLevitsky, VictorHarild Ottesen, LonePaz-Ares, Luis G.